EN
HI
Marksans Pharma share price chart
Marksans Pharma Share Key Metrics
Volume
19.60 L
Market Cap
14543.76 CR
LTQ@LTP
225@320.85
ATP
323.01
Var Margin
22.76 %
Circuit Range
260.9-391.3
Delivery %
28.86 %
Value
63.32 CR
ASM/GSM
No
Market Lot
1
Summary
MARKSANS stock price is ₹320.85 as of 20 Aug, 2026. The stock intraday movement has stayed between ₹318.50 and ₹328.55, while Marksans Pharma share price 52 week high low is ₹155.00 & ₹345.50.
In terms of trading activity, MARKSANS share price has recorded a volume of 19,60,211 shares. The Marksans Pharma has a market cap of ₹453288438. The stock’s Average Traded Price (ATP) stands at ₹323.01, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 225 @ ₹320.85.
The Marksans Pharma upper circuit limit is ₹391.30 & The Marksans Pharma lower circuit limit is ₹260.90, with a Value of ₹63.32 CR. The Delivery Percentage for the day is 28.86%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Marksans Pharma Fundamentals
P/E Ratio
28.72
P/B Ratio
4.67
Div. Yield
0.27
Sector P/E
65.06
Sector P/B
3.33
Sec. Div. Yield
0.51
Marksans Pharma Resistance and Support
Pivot 328.55
Resistance
First Resistance
333.75
Second Resistance
340.5
Third Resistance
345.7
Support
First Support
321.8
Second Support
316.6
Third Support
309.85
Marksans Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Aug 20 2026 | 328.5 | 320.85 | -1.88% | 328.55 | 318.5 |
| Wed Aug 19 2026 | 327.2 | 327 | 0.15% | 335.29 | 323.35 |
| Tue Aug 18 2026 | 331.79 | 326.5 | -1.49% | 336.35 | 325.2 |
Marksans Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-12 | Quarterly Results |
| 2026-05-26 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-19 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Marksans Pharma News
Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Marksans Pharma uploaded the audio recording of its Q1 FY27 investor and analyst conference call. The recording, held on August 13, 2026, is now available on the company's website for review.
Aug 13 2026 18:45:36
Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Marksans Pharma delivered record Q1 FY27 results with consolidated operating revenue reaching Rs.841 crore, a 35.6% YoY increase, and net profit soaring 173.9% YoY to Rs.159 crore. The company achieved all-time high EBITDA of Rs.213 crore and surpassed Rs.1,000 crore in cash balance.
Aug 12 2026 12:32:27
Read More
Marksans Pharma Management
| Name | Position |
|---|---|
| Harshavardhan Panigrahi | Company Secretary & Compliance Officer |
| Mark Saldanha | Chairman & Managing Director |
Marksans Pharma Similar Stocks
Dr. Agarwal's Health Care Ltd.
503.10
1.25 (0.25%)
Shilpa Medicare Ltd.
820.95
13.20 (1.63%)
Vijaya Diagnostic Centre Ltd.
1498.40
8.40 (0.56%)
Rainbow Children's Medicare Ltd.
1453.50
-8.30 (0.57%)
Jubilant Pharmova Ltd.
871.05
3.05 (0.35%)
CORONA Remedies Ltd.
2165.80
44.40 (2.09%)
Molbio Diagnostics Ltd.
1036.65
0.00 (0.00%)
Alivus Life Sciences Ltd.
1370.00
1.00 (0.07%)
Marksans Pharma FAQs
The Buying Price of Marksans Pharma share is 320.85 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Marksans Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Marksans Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Marksans Pharma shares is 28.72. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Marksans Pharma shares is 4.67. Useful to assess the stock's value relative to its book value.
To assess Marksans Pharma’s valuation compare Sector P/E, P/B which are 65.06 & 3.33 with sector averages, along with growth rates and financial metrics.
The Market Cap of Marksans Pharma is 14543.76 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Marksans Pharma share price is 345.50 & 155.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Marksans Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
